Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to afford their medicines.
Our efforts on behalf of patients and caregivers, access principles, commitment to diversity in clinical trials, and Patient Assistance Programs. Learn more Corporate ResponsibilityPopulation Health Our commitment to improving population health in heart disease. Learn moreThe Novartis US Foundation The miss...
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
In, EffectivenessSupport, PatientStrategy, MitigationBermangorvine, By Martin
Compositions of the invention will generally be administered directly to a patient. Direct delivery may be accomplished by parenteral injection (e.g. subcutaneously, intraperitoneally, intravenously, intramuscularly, or to the interstitial space of a tissue), or by rectal, oral, vaginal, topical, tra...
CancerPath to Care expands the 20-year access collaboration with The Max Foundation, previously known as CMLPath to Care, which focused on CML and other rare cancers. CMLPath to Care (originally launched as the Glivec®International Patient Assistance Program in 2002) provided medication at no ...
This includes answering questions about Zolgensma, verifying reimbursement assistance and coordinating financial assistance programs for eligible patients. For more information, caregivers and healthcare professionals can call 1-855-441-GENE (1-855-441-4363). Outsi...
Novartis created one of the most far-reaching access programs ever implemented on a global scale to ensure access to treatment for two rare forms of cancer.
programs. Interns will learn about BR’s approach to patient-driven research as they work on their own research project under the guidance of a BR scientist mentor at our research facilities in Cambridge, Massachusetts or San Diego, California. BR's research covers many disease, science, and ...